Kintara Therapeutics Inc (KTRA)

[jssdmm]

I agree. Also, the phase 3 trial design gives me confidence that VAL-083 will be efficacious vs the control which can be any number of treatments. If VAL-083 continues to show the same efficacy and follows the same pattern as previous trials then approval is more certain.

"....will feature a single randomized Phase 3 study measuring survival outcomes compared to a "physicians' choice" control, which, if successful, would serve as the basis for a New Drug Application (NDA) submission for VAL-083. The control arm will consist of a limited number of salvage chemotherapies currently utilized in the treatment of Avastin-failed GBM."

I think that a lot of the risks are mitigated with this stock vs other biotech companies. The volatility is natural as few know about DelMar since joining NASDAQ. I'm confident that management will drive awareness of val-083 and ALL of the potential utility across indications make this a great buying opportunity, IMHO. This drop is only a chance to buy in at a good price. With few sellers and buyers and low volume, a short (or someone selling to then buy warrants) could easily drive this down, but I do believe it will pop up even faster and higher.